Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology; D001011:Aorta / Q000637:transplantation; D004352:Drug Resistance, Microbial; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006349:Heart Valve Diseases / Q000188:drug therapy / Q000601:surgery; D006350:Heart Valve Prosthesis; D006556:Heroin Dependence / Q000150:complications; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D011113:Polymyxins / Q000008:administration & dosage*; D011549:Pseudomonas / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy*; D013444:Sulfisoxazole / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage* / Q000494:pharmacology; D014184:Transplantation, Homologous; D014261:Tricuspid Valve; D014295:Trimethoprim / Q000008:administration & dosage* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D013449:Sulfonamides; D013444:Sulfisoxazole; D014295:Trimethoprim